← Evidence library

BIB_429

EADO 2024 European consensus-based melanoma guideline — Part 2: Treatment (PMID 39709737) — ZERO-COVERAGE GAP: BIB330 covers Part 1 Diagnostics only; the Treatment companion has no prior BIB entry. The EADO guideline is the European peer to the ESMO CPG (BIB282) and the UK BAD/SIGN standards; its UK co-authors (Paul Lorigan, Christie Manchester; Paul Nathan, UCLH/Mount Vernon) ensure NHS-context credibility. KEY BRIEF RECOMMENDATION CHANGE: EADO 2024 Part 1 Diagnostics (extending the stub BIB330) states "From stage IB, lymph node sonography is recommended" — this DIVERGES from WoSCAN/SIGN 1…

Evidence grade

A

Tier

1 (EADO/EDF/EORTC European consensus

Cited by tasks

2, 4, 5, 24

Identifiers

DOI:10.1016/j · PMID:39709737

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_429/findings.md (research corpus). This page is a short context summary — not individualised medical advice.